Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Markers in a High-risk Cohort of Adults Undergoing Allogeneic Stem Cell Transplantation (SCT)

NCT07381205 is registered in ClinicalTrials.gov with Manuel Ricardo Espinoza-Gutarra as lead sponsor.

NCT NCT07381205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07381205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Markers in a High-risk Cohort of Adults Undergoing Allogeneic Stem Cell Transplantation (SCT)
Lead sponsor
Manuel Ricardo Espinoza-Gutarra
Phase
Observational
Overall status
Not yet recruiting
Start date
January 15, 2027
Completion date
November 30, 2028
Enrollment
85 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transplant associated microangiopathy tam, transplant complication